赛升药业(300485.SZ)：上半年净利润4778.62万元 同比扭亏

Core Viewpoint - Sai Sheng Pharmaceutical (300485.SZ) reported a decline in revenue for the first half of 2025, but achieved profitability in net profit compared to the previous year [1] Financial Performance - The company achieved operating revenue of 197 million yuan, representing a year-on-year decrease of 8.40% [1] - The net profit attributable to shareholders of the listed company was 47.79 million yuan, marking a turnaround from a loss to profit [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 8.64 million yuan, which is a year-on-year decrease of 52.21% [1] - Basic earnings per share were reported at 0.10 yuan [1]